Myeloma 2015 | Prospective targeted therapies for multiple myeloma

Philippe Moreau

At the Myeloma 2015 meeting, Prof Philippe Moreau (Centre Hospitalier Universitaire de Nantes, France) describes clinical studies of new treatments for multiple myeloma (MM) that are expected to publish results in the upcoming month. These studies include elotuzumab in combination with lenalidomide and dexamethasone for relapsed MM, daratumumab for advanced MM and carfilzomib for relapsed MM.

Share this video  
Similar topics